Ascendis Announces Plan to Repurchase $400 Million in Shares
2026-09-15 06:03:45
According to CoinMeta, Ascendis Pharma A /S (Nasdaq ticker: ASND) announced today that its board of directors has authorized the company to repurchase up to $400 million in common stock (stock repurchase plan).
Bullish 0
Bearish 0
Source:Internet
This content is for market information only and does not constitute investment advice.